Cargando…

Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease

Inflammation is one of the pathogenic processes in Parkinson’s disease (PD). Dopamine receptor agonist pramipexole (PPX) is extensively used for PD treatment in clinics. A number of studies show that PPX exerts neuroprotection on dopaminergic (DA) neurons, but the molecular mechanisms underlying the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, An-qi, Yang, Ya-ping, Jiang, Shu-min, Yao, Xiao-yu, Qi, Di, Mao, Cheng-jie, Cheng, Xiao-yu, Wang, Fen, Hu, Li-fang, Liu, Chun-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813225/ https://www.ncbi.nlm.nih.gov/pubmed/35896696 http://dx.doi.org/10.1038/s41401-022-00951-1

Ejemplares similares

BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease
por: Ying, Zhong-Ming, et al.
Publicado: (2022)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes
por: Gustin, Audrey, et al.
Publicado: (2015)

Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression
por: Du, Ren-Hong, et al.
Publicado: (2016)

Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression
por: Yu, Shui-Xing, et al.
Publicado: (2015)

Interplay Between NLRP3 Inflammasome and Autophagy
por: Biasizzo, Monika, et al.
Publicado: (2020)

Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018)

Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19
por: Yong, Yuan-Yuan, et al.
Publicado: (2022)

The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis
por: Tao, Ye, et al.
Publicado: (2020)

The Role of HDAC6 in Autophagy and NLRP3 Inflammasome
por: Chang, Panpan, et al.
Publicado: (2021)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome
por: Wang, Xiaohong, et al.
Publicado: (2020)

NLRP3 Inflammasome Activation by Viroporins of Animal Viruses
por: Guo, Hui-Chen, et al.
Publicado: (2015)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer
por: Liu, Shuang-Ge, et al.
Publicado: (2019)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
por: Fan, Zheng, et al.
Publicado: (2020)

lincRNA-Cox2 regulates NLRP3 inflammasome and autophagy mediated neuroinflammation
por: Xue, Zhenyi, et al.
Publicado: (2018)

The Role of the Interplay Between Autophagy and NLRP3 Inflammasome in Metabolic Disorders
por: Lv, Shuangyu, et al.
Publicado: (2021)

The Interplay between Autophagy and NLRP3 Inflammasome in Ischemia/Reperfusion Injury
por: Lv, Shuangyu, et al.
Publicado: (2021)

The Complex Interplay between Autophagy and NLRP3 Inflammasome in Renal Diseases
por: Ding, Yong, et al.
Publicado: (2021)

The role and mechanism of NLRP3 inflammasome-mediated astrocyte activation in dehydrocorydaline against CUMS-induced depression
por: Fang, Yu, et al.
Publicado: (2022)

The NLRP3 inflammasome in viral infection (Review)
por: Zheng, Qiaoli, et al.
Publicado: (2023)

The role of NLRP3 inflammasome in stroke and central poststroke pain
por: Li, Shao-jun, et al.
Publicado: (2018)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2018)

CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson’s disease by targeting miR-7
por: Sang, Qiuling, et al.
Publicado: (2018)

Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
por: Sun, Guoqing, et al.
Publicado: (2022)

The AST-120 Recovers Uremic Toxin-Induced Cognitive Deficit via NLRP3 Inflammasome Pathway in Astrocytes and Microglia
por: Li, Lung-Chih, et al.
Publicado: (2021)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly
por: Ding, Wenwen, et al.
Publicado: (2020)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
por: Lv, Qi, et al.
Publicado: (2021)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
por: Chang, Yu-Wei, et al.
Publicado: (2021)

NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
por: Freeman, Leslie, et al.
Publicado: (2017)

NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia
por: She, Ningning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hbm2jh283i92pcphdl3vqh35sp